National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis

In this podcast accompanying the July issue of DTB ( ), David Phizackerley (DTB Editor) is joined by Syba Sunny (Clinical Editor). David and Syba discuss the editorial ( ) which focuses on some key changes in the new national asthma guideline and the implications for patients and healthcare professionals. A DTB Select article ( ) provides an overview of a double-blind randomised placebo-controlled trial that assessed whether bisoprolol reduced the number of exacerbations in people with COPD. The main article ( ) is an overview of abaloparatide, which is licensed for the treatment of osteoporosis in postmenopausal women at increased risk of fracture. The podcast begins with a discussion about ideas for new articles for DTB and the therapeutic areas currently under consideration. If you have a suggestion for an article that you would like DTB to cover, please email details to dtb@bmj.com . Please

You can listen to National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis online on Radio and Podcast. Open the player on this page to stream the available audio.

National asthma guidelines, bisoprolol for COPD and abaloparatide for osteoporosis is an episode from DTB podcast by BMJ Group.

This episode is 22:52 long.

This episode was published on Jul 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from DTB podcast when more episodes are available from the podcast feed.